Patents by Inventor Sofie Van Huffel

Sofie Van Huffel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Abin-mediated hepatitis protection
    Patent number: 7094756
    Abstract: The present invention relates to the use of the A20-binding inhibitor of NF-?B activation (ABIN), or a functional fragment or variant thereof to protect against TNF-induced liver failure, such as viral hepatitis and alcoholic liver disease. More particularly, it relates to the prevention of the toxic effects of said diseases, including lethality, by overexpressing ABIN.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: August 22, 2006
    Assignee: Vlaams Interuniversitair Instituut Voor Biotechnologie VZW
    Inventors: Rudi Beyaert, Ben Wielockx, Sofie Van Huffel, Filip Delaei, Claude Libert
  • Abin-mediated hepatitis protection
    Publication number: 20040136978
    Abstract: The present invention relates to the use of the A20-binding inhibitor of NF-&kgr;B activation (ABIN), or a functional fragment or variant thereof to protect aGalNst TNF-induced liver failure, such as viral hepatitis and alcoholic liver disease. More particularly, it relates to the prevention of the toxic effects of said diseases, including lethality, by overexpressing ABIN.
    Type: Application
    Filed: December 19, 2003
    Publication date: July 15, 2004
    Inventors: Rudi Beyaert, Ben Wielockx, Sofie Van Huffel, Filip Delaei, Claude Libert